search
Back to results

Randomized Clinical Trial by Conglomerates on the Efficacy of Maintenance of Physical Exercise in Myocardial Ischemia (CarPE3)

Primary Purpose

Myocardial Ischemia, Physical Exercise

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Maintenance of physical exercise
Sponsored by
Núria Santaularia Capdevila
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Myocardial Ischemia focused on measuring Cardiac Rehabilitation, Myocardial Ischemia, Physical Exercise, Cardiovascular Risk Factors, Randomized Controlled Trial

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients diagnosed with myocardial ischemia, angina pectoris, other specific forms of chronic ischemic heart disease or unspecified ischemic heart disease.
  • Patients who have completed the supervised physical exercise program of phase II of the CRP.
  • Absence of cognitive deficit (Pfeiffer test: 0-2 mistakes).
  • Sufficient functional capacity to follow the CRP (Barthel index >60)
  • Residence in catchment area of Bages and Moianès.
  • Providing signed informed consent.

Exclusion Criteria:

  • Symptoms of right heart failure producing pulmonary hypertension.
  • Dyspnea caused by severe pulmonary pathology.
  • Additional comorbidities affecting the prognosis of cardiac disease.
  • Major comorbidities or limitations that could interfere with the exercise training programme.

Sites / Locations

  • Althaia Xarxa Assistencial Universitària de Manresa

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control group

Intervention group

Arm Description

The usual care in patients with myocardial ischemia without other cardiovascular risk factors (CVFR) will be to attend one visit per year with doctor and nurse of the local health center. In this visit, it will be done a blood test and an electrocardiogram. Blood pressure, weight, body mass index, abdominal circumference will be measured and, in case of detecting enolic habit, smoking or sedentary lifestyle, generic advice will be done. If the patient, apart from myocardial ischemia, presents diabetes mellitus type 2, 3-4 follow-up visits per year will be recommended and will be increased according to specific needs. In case of presenting hypertension, will be recommended 2 visits with the nurse and one visit with the doctor per year and will be increased according to specific needs. In addition, in this case the blood pressure is checked every 6 months. During all visits, professionals will reinforce the control of CVRF and the maintenance of a long-term cardio-healthy lifestyle.

Patient will go to health center to visit the cardiac rehabilitation (CR) reference team, which is composed for a doctor and a nurse. This team will establish the guideline of action in the maintenance and/or increase in the physical exercise practice, in function of the resources of each zone and the preferences and motivations of the patient. They also reinforce the control of CVRF and the maintenance of a long-term cardio-healthy lifestyle. At the end of the visit, control visit will be given with the CR reference team at 3, 6 and 12 months after completing the supervised physical exercise program of phase II of the CRP. In case of detecting specific needs for the patient and/or relapses, the team will consult with the appropriate professional (cardiologist, cardiology nurse, physiotherapist, rehabilitator, nutritionist and/or psychologist). At the same time, the patient will be informed of the possibility of re-evaluating the CR reference team.

Outcomes

Primary Outcome Measures

The physical exercise minutes performed by the patient per week
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
The physical exercise minutes performed by the patient per week
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
The physical exercise minutes performed by the patient per week
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.

Secondary Outcome Measures

The energy expenditure by the patient per week
The energy expenditure by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
The energy expenditure by the patient per week
The energy expenditure by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
The energy expenditure by the patient per week
The energy expenditure by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
The body mass index (BMI)
BMI is the quotient between the weight (kg) and the square of the height (m). It is usually used for the definition of underweight (BMI <15.99), normal weight (BMI 18.5 to 24.99), overweight (BMI ≥ 25 kg / m2) and obesity (BMI ≥ 30 kg / m2).
The body mass index (BMI)
BMI is the quotient between the weight (kg) and the square of the height (m). It is usually used for the definition of underweight (BMI <15.99), normal weight (BMI 18.5 to 24.99), overweight (BMI ≥ 25 kg / m2) and obesity (BMI ≥ 30 kg / m2).
The abdominal circumference
Abdominal circumference is the measurement of the abdomen of the patient at the level of the navel. It will be recorded in centimeters using a tape measure.
The abdominal circumference
Abdominal circumference is the measurement of the abdomen of the patient at the level of the navel. It will be recorded in centimeters using a tape measure.
The control of smoking
Smoking:The degree of dependence on tobacco consumption will be recorded through the Fargeström test.
The control of smoking
Smoking:The degree of dependence on tobacco consumption will be recorded through the Fargeström test.
The control of smoking
Smoking:The degree of dependence on tobacco consumption will be recorded through the Fargeström test.
Systolic blood pressure
Physiological parameter
Systolic blood pressure
Physiological parameter
Systolic blood pressure
Physiological parameter
Diastolic blood pressure
Physiological parameter
Diastolic blood pressure
Physiological parameter
Diastolic blood pressure
Physiological parameter
Total cholesterol
Physiological parameter
Total cholesterol
Physiological parameter
Total cholesterol
Physiological parameter
Low-density lipoproteins cholesterol
Physiological parameter
Low-density lipoproteins cholesterol
Physiological parameter
Low-density lipoproteins cholesterol
Physiological parameter
High-density lipoproteins cholesterol
Physiological parameter
High-density lipoproteins cholesterol
Physiological parameter
High-density lipoproteins cholesterol
Physiological parameter
Triglycerides
Physiological parameter
Triglycerides
Physiological parameter
Triglycerides
Physiological parameter
Basal plasma glucose
Physiological parameter
Basal plasma glucose
Physiological parameter
Basal plasma glucose
Physiological parameter
The quality of life related to health.
Level of perception of the patient regarding their state of health. It will be measured through the EuroQol-5D test.
The quality of life related to health.
Level of perception of the patient regarding their state of health. It will be measured through the EuroQol-5D test.
The quality of life related to health.
Level of perception of the patient regarding their state of health. It will be measured through the EuroQol-5D test.
Assess the adherence to cardiovascular medication.
It will be recorded if the patient is successfully taking the cardiovascular medication through the Haynes-Sackett test.
Assess the adherence to cardiovascular medication.
It will be recorded if the patient is successfully taking the cardiovascular medication through the Haynes-Sackett test.
Assess the adherence to cardiovascular medication.
It will be recorded if the patient is successfully taking the cardiovascular medication through the Haynes-Sackett test.

Full Information

First Posted
July 19, 2019
Last Updated
October 27, 2022
Sponsor
Núria Santaularia Capdevila
Collaborators
Institut Català de la Salut
search

1. Study Identification

Unique Protocol Identification Number
NCT04251611
Brief Title
Randomized Clinical Trial by Conglomerates on the Efficacy of Maintenance of Physical Exercise in Myocardial Ischemia
Acronym
CarPE3
Official Title
Randomized Clinical Trial by Conglomerates on the Efficacy of the Maintenance of Physical Exercise for Patients With Myocardial Ischemia. Study Cardiopathy Prevention and Exercise in Phase 3 (CarPE3)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2019 (Actual)
Primary Completion Date
May 30, 2022 (Actual)
Study Completion Date
May 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Núria Santaularia Capdevila
Collaborators
Institut Català de la Salut

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Main objective: To assess the efficacy of a phase III cardiac rehabilitation program (CRP), based on counseling in the maintenance of physical exercise (time of physical exercise per week) for patients with myocardial ischemia (MI), once the supervised physical exercise program of phase II of CRP is completed. Secondary objectives: To assess the efficacy of a phase III program of CRP based on counseling in the maintenance of physical exercise for the patient with MI in: 1) the energy expenditure per week, 2) body mass index and abdominal perimeter, 3) control of cardiovascular risk factors (smoking, high blood pressure, dyslipidemia and diabetes mellitus), 4) quality of life related to health, 5) assess the adherence to cardiac pharmacological treatment. Method: Randomized clinical trial in conglomerates, open and controlled. The intervention group will carry out phase III of CRP based on counseling in the maintenance of physical exercise. The control group will receive the usual care. The main outcome will be the physical exercise time per week after finish the supervised physical exercise program of phase II of CRP and at 6 and 12 month later according to the 7-day Physical Activity Recall.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Ischemia, Physical Exercise
Keywords
Cardiac Rehabilitation, Myocardial Ischemia, Physical Exercise, Cardiovascular Risk Factors, Randomized Controlled Trial

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
101 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
The usual care in patients with myocardial ischemia without other cardiovascular risk factors (CVFR) will be to attend one visit per year with doctor and nurse of the local health center. In this visit, it will be done a blood test and an electrocardiogram. Blood pressure, weight, body mass index, abdominal circumference will be measured and, in case of detecting enolic habit, smoking or sedentary lifestyle, generic advice will be done. If the patient, apart from myocardial ischemia, presents diabetes mellitus type 2, 3-4 follow-up visits per year will be recommended and will be increased according to specific needs. In case of presenting hypertension, will be recommended 2 visits with the nurse and one visit with the doctor per year and will be increased according to specific needs. In addition, in this case the blood pressure is checked every 6 months. During all visits, professionals will reinforce the control of CVRF and the maintenance of a long-term cardio-healthy lifestyle.
Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Patient will go to health center to visit the cardiac rehabilitation (CR) reference team, which is composed for a doctor and a nurse. This team will establish the guideline of action in the maintenance and/or increase in the physical exercise practice, in function of the resources of each zone and the preferences and motivations of the patient. They also reinforce the control of CVRF and the maintenance of a long-term cardio-healthy lifestyle. At the end of the visit, control visit will be given with the CR reference team at 3, 6 and 12 months after completing the supervised physical exercise program of phase II of the CRP. In case of detecting specific needs for the patient and/or relapses, the team will consult with the appropriate professional (cardiologist, cardiology nurse, physiotherapist, rehabilitator, nutritionist and/or psychologist). At the same time, the patient will be informed of the possibility of re-evaluating the CR reference team.
Intervention Type
Other
Intervention Name(s)
Maintenance of physical exercise
Other Intervention Name(s)
Strengthen the control of cardiovascular risk factors
Intervention Description
Objectives will be established with the patient to increase the practice of physical exercise and reinforce the control of cardiovascular risk factors (CVRF) and the maintenance of a long-term cardio-healthy lifestyle.
Primary Outcome Measure Information:
Title
The physical exercise minutes performed by the patient per week
Description
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
The physical exercise minutes performed by the patient per week
Description
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The physical exercise minutes performed by the patient per week
Description
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Secondary Outcome Measure Information:
Title
The energy expenditure by the patient per week
Description
The energy expenditure by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
The energy expenditure by the patient per week
Description
The energy expenditure by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The energy expenditure by the patient per week
Description
The energy expenditure by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The body mass index (BMI)
Description
BMI is the quotient between the weight (kg) and the square of the height (m). It is usually used for the definition of underweight (BMI <15.99), normal weight (BMI 18.5 to 24.99), overweight (BMI ≥ 25 kg / m2) and obesity (BMI ≥ 30 kg / m2).
Time Frame
At baseline of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The body mass index (BMI)
Description
BMI is the quotient between the weight (kg) and the square of the height (m). It is usually used for the definition of underweight (BMI <15.99), normal weight (BMI 18.5 to 24.99), overweight (BMI ≥ 25 kg / m2) and obesity (BMI ≥ 30 kg / m2).
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The abdominal circumference
Description
Abdominal circumference is the measurement of the abdomen of the patient at the level of the navel. It will be recorded in centimeters using a tape measure.
Time Frame
At baseline of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The abdominal circumference
Description
Abdominal circumference is the measurement of the abdomen of the patient at the level of the navel. It will be recorded in centimeters using a tape measure.
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The control of smoking
Description
Smoking:The degree of dependence on tobacco consumption will be recorded through the Fargeström test.
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
The control of smoking
Description
Smoking:The degree of dependence on tobacco consumption will be recorded through the Fargeström test.
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The control of smoking
Description
Smoking:The degree of dependence on tobacco consumption will be recorded through the Fargeström test.
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Systolic blood pressure
Description
Physiological parameter
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
Systolic blood pressure
Description
Physiological parameter
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Systolic blood pressure
Description
Physiological parameter
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Diastolic blood pressure
Description
Physiological parameter
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
Diastolic blood pressure
Description
Physiological parameter
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Diastolic blood pressure
Description
Physiological parameter
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Total cholesterol
Description
Physiological parameter
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
Total cholesterol
Description
Physiological parameter
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Total cholesterol
Description
Physiological parameter
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Low-density lipoproteins cholesterol
Description
Physiological parameter
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
Low-density lipoproteins cholesterol
Description
Physiological parameter
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Low-density lipoproteins cholesterol
Description
Physiological parameter
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
High-density lipoproteins cholesterol
Description
Physiological parameter
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
High-density lipoproteins cholesterol
Description
Physiological parameter
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
High-density lipoproteins cholesterol
Description
Physiological parameter
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Triglycerides
Description
Physiological parameter
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
Triglycerides
Description
Physiological parameter
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Triglycerides
Description
Physiological parameter
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Basal plasma glucose
Description
Physiological parameter
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
Basal plasma glucose
Description
Physiological parameter
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Basal plasma glucose
Description
Physiological parameter
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The quality of life related to health.
Description
Level of perception of the patient regarding their state of health. It will be measured through the EuroQol-5D test.
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
The quality of life related to health.
Description
Level of perception of the patient regarding their state of health. It will be measured through the EuroQol-5D test.
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
The quality of life related to health.
Description
Level of perception of the patient regarding their state of health. It will be measured through the EuroQol-5D test.
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Assess the adherence to cardiovascular medication.
Description
It will be recorded if the patient is successfully taking the cardiovascular medication through the Haynes-Sackett test.
Time Frame
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
Title
Assess the adherence to cardiovascular medication.
Description
It will be recorded if the patient is successfully taking the cardiovascular medication through the Haynes-Sackett test.
Time Frame
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
Title
Assess the adherence to cardiovascular medication.
Description
It will be recorded if the patient is successfully taking the cardiovascular medication through the Haynes-Sackett test.
Time Frame
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients diagnosed with myocardial ischemia, angina pectoris, other specific forms of chronic ischemic heart disease or unspecified ischemic heart disease. Patients who have completed the supervised physical exercise program of phase II of the CRP. Absence of cognitive deficit (Pfeiffer test: 0-2 mistakes). Sufficient functional capacity to follow the CRP (Barthel index >60) Residence in catchment area of Bages and Moianès. Providing signed informed consent. Exclusion Criteria: Symptoms of right heart failure producing pulmonary hypertension. Dyspnea caused by severe pulmonary pathology. Additional comorbidities affecting the prognosis of cardiac disease. Major comorbidities or limitations that could interfere with the exercise training programme.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Núria Santaularia, MSc, PhD
Organizational Affiliation
Althaia Xarxa Assistencial Universitària de Manresa
Official's Role
Principal Investigator
Facility Information:
Facility Name
Althaia Xarxa Assistencial Universitària de Manresa
City
Manresa
State/Province
Barcelona
ZIP/Postal Code
08243
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Data will be shared with a request of researchers. All the information will be anonymous.
IPD Sharing Time Frame
When final results of the study will be published.
IPD Sharing Access Criteria
Data will be shared with researchers or research team with a protocol study approved and/or with a clinical trial registred at a clinical trial register.

Learn more about this trial

Randomized Clinical Trial by Conglomerates on the Efficacy of Maintenance of Physical Exercise in Myocardial Ischemia

We'll reach out to this number within 24 hrs